⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of JAFRAL d.o.o. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
JAFRAL d.o.o.
↗Ljubljana, Slovenia
JAFRAL is a specialized Contract Development and Manufacturing Organization (CDMO) based in Ljubljana, Slovenia, founded in 2011. The company is globally recognized for its expertise in bacteriophage production and has expanded its platform to provide end-to-end manufacturing services for a wide range of biologics, including plasmid DNA, mRNA, recombinant proteins, outer membrane vesicles (OMVs), and live biotherapeutic products (LBPs).
Operating from GMP-compliant facilities, JAFRAL supports the biotechnology and pharmaceutical industries by offering services ranging from process development and scale-up to routine commercial production and Fill & Finish. The company focuses on accelerating the development of next-generation therapies, including gene and cell therapies, while actively contributing to the global fight against antimicrobial resistance (AMR).
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:
Industry:CDMO
Sub-Industry:Bacteriophage and Biologics Manufacturing
SIZE & FINANCIALS
Employees:1-50
Founded:2011
Ownership:private
Status:operating
PIPELINE
Stage:N/A
Lead Drug Stage:N/A
Modalities:Bacteriophages, Plasmid DNA, mRNA, Recombinant proteins, OMVs, LBPs
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Bio-Pharm Competence Center for Biotechnology and Pharmaceuticals
COMPETITION
Position:Niche Player
Competitors:WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals, Red Nucleus
LEADERSHIP
Key Executives:
Dr. Smrekar - Representative/Executive
LINKS
Website:jafral.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with JAFRAL d.o.o.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.